17th Open Scientific EIP Symposium on Immunogenicity of Biopharmaceuticals

16 - 19 March, 2026

Lisbon, Portugal

Visit us at BOOTH "Darwin"

We look forward to meeting you at EIP.

Request a meeting with our team in Lisbon to learn how we help our clients advance their therapeutic drug programs.   

EIP European Immunogenicity Platform Symposium logo

BioAgilytix Presentation at EIP

florian anlauff
Overcoming Unexpected Interference in a Highly Drug-Tolerant and Ultrasensitive ADA-SPEAD Assay
Florian Anlauff, PhD, Scientific Operations 
Tuesday, 17 March | 14:30

BioAgilytix Poster at EIP

MinhDang
Practical Considerations for Immunogenicity Assessment in CAR-T Cell Therapy Programs
Minh Dang, PhD, Scientific Operations 
Wednesday, 18 March | 12:30

Partner with BioAgilytix for your immunogenicity project

BioAgilytix’s scientists are experts in the assessment of humoral and cellular immune responses to biotherapeutic modalities. When you partner with BioAgilytix you are connected to:

  • Regulated data to support immunogenicity risk assessment for all biotherapeutics

  • Support for global trials with labs in the U.S., Europe, and Australia

  • Over 10 years of experience in immunogenicity risk assessment

  • Experience in supporting studies in various species, including rodents, humans, and non-human primates

BioAgilytix has proven experience assessing immunogenicity for therapeutic modalities, including:

  • ADA and NAb testing for large molecules and ATMPs

  • Assays for detection of cellular immunogenicity

  • Measurements of cytokine production Reagent labeling and oversight of surrogate positive control antibody generation

  • Statistical analysis to support cut point generation   

About the event 

The European Immunogenicity Platform (EIP) acts as a central meeting place for European biopharmaceutical companies and scientific experts active in the area of immunogenicity. Its mission is to increase knowledge and expertise in the field of immunogenicity, fostered by close interactions between industry and scientific advisors. EIP represents companies, institutes and professionals involved in research, development, testing, validation, application, production or marketing of immunogenicity assessment tools, as well as those servicing the biotechnology community.

iStock-1449602358 (1)

Schedule a meeting with our experts on site

Speak with our team about how the combination of world-class scientific expertise, outstanding project management, and superior regulatory insight can expedite your advanced therapeutic. You can also fill out the form and an expert will reach out to schedule a meeting with you onsite.  

© Copyright 2026 BioAgilytix Labs. All rights reserved.

icon-linkedin-footer